Pharmaxis provides FDA resubmission for Aridol US marketing application
27th
Apr 10
Release Date: 27/04/2010 12:00am
Pharmaxis today announced that the U.S. Food and Drug Administration has acknowledged receipt of the resubmission of its New Drug Application for Aridolâ„¢ (mannitol inhalation powder).
Â
Categories: News and Media